Understanding short-term transmission dynamics of methicillin-resistant


Journal

Infection control and hospital epidemiology
ISSN: 1559-6834
Titre abrégé: Infect Control Hosp Epidemiol
Pays: United States
ID NLM: 8804099

Informations de publication

Date de publication:
09 2022
Historique:
pubmed: 28 8 2021
medline: 20 9 2022
entrez: 27 8 2021
Statut: ppublish

Résumé

Little is known about the short-term dynamics of methicillin-resistant Observational pilot study. Two hospitals, hospital 1 in Zurich, Switzerland, and hospital 2 in Ann Arbor, Michigan, United States. Inpatients with MRSA colonization or infection. At baseline, the groin, axilla, nares, dominant hands of 10 patients and 6 environmental high-touch surfaces in their rooms were sampled. Cultures were then taken of the patient hand and high-touch surfaces 3 more times at 90-minute intervals. After each swabbing, patients' hands and surfaces were disinfected. Patient activity was assessed by interviews at hospital 1 and analysis of video footage at hospital 2. A contamination pressure score was created by multiplying the number of colonized body sites with the activity level of the patient. In total, 10 patients colonized and/or infected with MRSA were enrolled; 40 hand samples and 240 environmental samples were collected. At baseline, 30% of hands and 20% of high-touch surfaces yielded MRSA. At follow-up intervals, 8 (27%) of 30 patient hands, and 10 (6%) of 180 of environmental sites were positive. Activity of the patient explained 7 of 10 environmental contaminations. Patients with higher contamination pressure score showed a trend toward higher environmental contamination. Environmental MRSA contamination in patient rooms was highly dynamic and was likely driven by the patient's MRSA body colonization pattern and the patient activity.

Identifiants

pubmed: 34448445
pii: S0899823X21003500
doi: 10.1017/ice.2021.350
pmc: PMC9272746
mid: NIHMS1814121
doi:

Types de publication

Journal Article Observational Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1147-1154

Subventions

Organisme : NIA NIH HHS
ID : K24 AG050685
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG024824
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002240
Pays : United States
Organisme : NIA NIH HHS
ID : T32 AG062403
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG041780
Pays : United States

Références

Infect Control Hosp Epidemiol. 2018 Sep;39(9):1093-1107
pubmed: 30039774
Infect Control Hosp Epidemiol. 2015 Feb;36(2):229-31
pubmed: 25633009
J Hosp Infect. 2007 Sep;67(1):9-21
pubmed: 17719685
Clin Microbiol Infect. 2010 May;16(5):425-31
pubmed: 19689469
J Hosp Infect. 2006 Feb;62(2):187-94
pubmed: 16290319
J Clin Microbiol. 2006 Feb;44(2):637-9
pubmed: 16455933
J Hosp Infect. 2010 Mar;74(3):296-9
pubmed: 20153081
Open Forum Infect Dis. 2019 Mar 15;6(Suppl 1):S47-S53
pubmed: 30895214
Clin Infect Dis. 2019 Nov 13;69(11):1837-1844
pubmed: 30980082
Am J Infect Control. 2013 May;41(5 Suppl):S6-11
pubmed: 23622751
Int J Hyg Environ Health. 2009 Mar;212(2):209-15
pubmed: 18667356
Infect Control Hosp Epidemiol. 2011 Feb;32(2):185-7
pubmed: 21460476
Infect Control Hosp Epidemiol. 1997 Sep;18(9):622-7
pubmed: 9309433
J Hosp Infect. 2001 Dec;49(4):255-61
pubmed: 11740873
Infect Control Hosp Epidemiol. 2019 Mar;40(3):328-332
pubmed: 30777587
Indian J Crit Care Med. 2012 Jul;16(3):123-9
pubmed: 23188950
J Hosp Infect. 2015 Nov;91(3):211-7
pubmed: 26365827
Infect Control Hosp Epidemiol. 2019 Apr;40(4):447-456
pubmed: 30837029
J Hosp Infect. 2002 Jun;51(2):140-3
pubmed: 12090803
J Hosp Infect. 2002 Jan;50(1):30-5
pubmed: 11825049
Clin Infect Dis. 2009 May 15;48(10):1423-8
pubmed: 19364286
Med Care. 2017 Oct;55(10):e73-e80
pubmed: 25924079
Lancet Infect Dis. 2008 May;8(5):289-301
pubmed: 18471774
J Clin Microbiol. 2005 Apr;43(4):1925-7
pubmed: 15815020

Auteurs

Aline Wolfensberger (A)

Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Nora Mang (N)

Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Kristen E Gibson (KE)

Division of Geriatric and Palliative Medicine, University of Michigan, Ann Arbor, Michigan, United States.

Kyle Gontjes (K)

Division of Geriatric and Palliative Medicine, University of Michigan, Ann Arbor, Michigan, United States.

Marco Cassone (M)

Division of Geriatric and Palliative Medicine, University of Michigan, Ann Arbor, Michigan, United States.

Silvio D Brugger (SD)

Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Lona Mody (L)

Division of Geriatric and Palliative Medicine, University of Michigan, Ann Arbor, Michigan, United States.
Geriatrics Research Education and Clinical Center (GRECC), VA Ann Arbor Healthcare System, Ann Arbor, Michigan, United States.

Hugo Sax (H)

Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Department of Infectious Diseases, Bern University Hospital and University of Bern, Bern, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH